Librium

Chlordiazepoxide, the active ingredient in Librium, is a benzodiazepine presented as an oral tablet for oral use. It is prescribed to manage anxiety disorders, alleviate symptoms of acute alcohol withdrawal, and provide sedation before medical procedures, primarily in adult patients.

GNH USA supplies Librium as a licensed, GDP‑compliant international pharmaceutical supplier, adhering to stringent quality standards and regulatory requirements while serving hospitals, pharmacies and clinics worldwide with reliable, on‑time delivery. Our global network ensures consistent product availability across Europe, Asia and the Americas.

Chlordiazepoxide is indicated for several anxiety‑related and withdrawal conditions, acting on the central nervous system to reduce excessive neuronal activity.

Anxiety disorders: reduces excessive worry and tension, facilitating calmness in adult patients. Acute alcohol withdrawal syndrome: alleviates tremor, agitation and risk of seizures during early detoxification. Procedural sedation: provides short‑term sedation and anxiolysis before diagnostic or therapeutic medical procedures.

Common Side Effects: - Drowsiness or fatigue - Dizziness or light‑headedness - Impaired coordination or ataxia - Memory impairment or difficulty concentrating - Blurred vision or visual disturbances - Gastrointestinal upset such as nausea

Serious or Rare Side Effects: - Respiratory depression, especially with high doses or concurrent depressants - Severe hypotension or cardiovascular collapse - Paradoxical reactions including aggression, agitation, or hallucinations - Dependence, tolerance, and withdrawal seizures upon abrupt discontinuation - Hepatic dysfunction or jaundice in rare cases

Before initiating therapy, evaluate patient history and comorbid conditions.

Assess patient history: screen for respiratory depression, hepatic impairment, substance‑use disorder, and concomitant CNS depressants. Avoid abrupt discontinuation: taper under medical supervision to prevent withdrawal seizures and rebound anxiety. Use caution in elderly: increased sensitivity to sedation, falls, and cognitive impairment. Pregnancy: Category D – discuss potential risks versus benefits with obstetric care provider. Avoid concomitant CNS depressants: limit use with opioids, alcohol, antihistamines, or other sedatives. Store at ambient temperature: keep tablets in original container, protect from moisture and light.

Chlordiazepoxide may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Opioids: additive respiratory depression and profound sedation. - Alcohol: enhanced CNS depression, increasing risk of overdose. - Other benzodiazepines or barbiturates: cumulative sedative effects and respiratory compromise.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase overall sedation. - Antihistamines: heightened drowsiness and impaired coordination. - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): can raise chlordiazepoxide plasma concentrations, necessitating dose adjustment.